These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 2061928)
21. Discovery of novel tricyclic compounds as squalene synthase inhibitors. Ichikawa M; Ohtsuka M; Ohki H; Haginoya N; Itoh M; Sugita K; Usui H; Suzuki M; Terayama K; Kanda A Bioorg Med Chem; 2012 May; 20(9):3072-93. PubMed ID: 22464687 [TBL] [Abstract][Full Text] [Related]
22. Subcellular localization of squalene synthase in rat hepatic cells. Biochemical and immunochemical evidence. Stamellos KD; Shackelford JE; Shechter I; Jiang G; Conrad D; Keller GA; Krisans SK J Biol Chem; 1993 Jun; 268(17):12825-36. PubMed ID: 8509416 [TBL] [Abstract][Full Text] [Related]
23. Pharmacological characterization in vitro of EP2306 and EP2302, potent inhibitors of squalene synthase and lipid biosynthesis. Tavridou A; Kaklamanis L; Megaritis G; Kourounakis AP; Papalois A; Roukounas D; Rekka EA; Kourounakis PN; Charalambous A; Manolopoulos VG Eur J Pharmacol; 2006 Mar; 535(1-3):34-42. PubMed ID: 16545796 [TBL] [Abstract][Full Text] [Related]
24. 1,1-Bisphosphonate squalene synthase inhibitors: interplay between the isoprenoid subunit and the diphosphate surrogate. Magnin DR; Biller SA; Dickson JK; Logan JV; Lawrence RM; Chen Y; Sulsky RB; Ciosek CP; Harrity TW; Jolibois KG J Med Chem; 1995 Jul; 38(14):2596-605. PubMed ID: 7629799 [TBL] [Abstract][Full Text] [Related]
25. Effect of alkyl phosphates on beta-glucuronidase in rats: release of beta-glucuronidase from liver microsomes into serum. Suzuki Y; Kikuchi H; Kato C; Horiuchi Y; Tomita K Biochem Pharmacol; 1977 May; 26(9):881-5. PubMed ID: 861054 [No Abstract] [Full Text] [Related]
26. Selective protection and relative importance of the carboxylic acid groups of zaragozic acid A for squalene synthase inhibition. Biftu T; Acton JJ; Berger GD; Bergstrom JD; Dufresne C; Kurtz MM; Marquis RW; Parsons WH; Rew DR; Wilson KE J Med Chem; 1994 Feb; 37(3):421-4. PubMed ID: 8308869 [TBL] [Abstract][Full Text] [Related]
27. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase. Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381 [TBL] [Abstract][Full Text] [Related]
28. Different analogues of farnesyl pyrophosphate inhibit squalene synthase and protein:farnesyltransferase to different extents. Cohen LH; Valentijn AR; Roodenburg L; Van Leeuwen RE; Huisman RH; Lutz RJ; Van der Marel GA; Van Boom JH Biochem Pharmacol; 1995 Mar; 49(6):839-45. PubMed ID: 7702642 [TBL] [Abstract][Full Text] [Related]